Clinical Trial: ECOG-ACRIN EAY191

ECOG-ACRIN EAY191

Status: Open

NCT#05564377

Molecular Analysis for Combination Therapy Choice (ComboMATCH)
(A screening trial for EAY191-A3 , EAY191-A6, EAY191-E4, EAY191-E5, EAY191-N2, EAY191-N4, EAY191-N5, and EAY191-S3.)

Eligible for screening study DCP 001

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved